{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:05:43Z","timestamp":1790283943247,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ICI24\/00105"],"award-info":[{"award-number":["ICI24\/00105"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FORT23\/00008"],"award-info":[{"award-number":["FORT23\/00008"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.lanmic.2025.101255","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:50:35Z","timestamp":1761882635000},"page":"101255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["P2Y12 inhibitors in Staphylococcus aureus bacteraemia: current evidence and clinical implications"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-9584","authenticated-orcid":false,"given":"Emanuele","family":"Rando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Eduardo","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2025.101255_bib1","article-title":"Incidence trends and epidemiology of Staphylococcus aureus bacteremia: a systematic review of population-based studies","volume":"14","author":"Hindy","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.lanmic.2025.101255_bib2","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jamainternmed.2017.3958","article-title":"Association of evidence-based care processes with mortality in Staphylococcus aureus bacteremia at Veterans Health Administration hospitals, 2003\u20132014","volume":"177","author":"Goto","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.lanmic.2025.101255_bib3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3201\/eid2505.181773","article-title":"Age-dependent increase in incidence of Staphylococcus aureus bacteremia, Denmark, 2008\u20132015","volume":"25","author":"Thorlacius-Ussing","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101255_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","article-title":"Infectious disease consultation for Staphylococcus aureus bacteremia\u2014a systematic review and meta-analysis","volume":"72","author":"Vogel","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.lanmic.2025.101255_bib5","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lanmic.2025.101255_bib6","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJMoa2300220","article-title":"Ceftobiprole for treatment of complicated Staphylococcus aureus bacteremia","volume":"389","author":"Holland","year":"2023","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"10.1016\/j.lanmic.2025.101255_bib7","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1093\/cid\/cis559","article-title":"Summary of ceftaroline fosamil clinical trial studies and clinical safety","volume":"55","author":"File","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101255_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cid\/civ982","article-title":"A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection","volume":"62","author":"Dunne","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101255_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cid\/ciu778","article-title":"Single-dose oritavancin versus 7\u201310 days of vancomycin in the treatment of Gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study","volume":"60","author":"Corey","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101255_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/cit499","article-title":"Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia","volume":"57","author":"L\u00f3pez-Cort\u00e9s","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101255_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4049\/jimmunol.1601178","article-title":"Platelets mediate host defense against Staphylococcus aureus through direct bactericidal activity and by enhancing macrophage activities","volume":"198","author":"Ali","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.lanmic.2025.101255_bib12","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2001-12-0191","article-title":"Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation","volume":"99","author":"Youssefian","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.lanmic.2025.101255_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fimmu.2015.00083","article-title":"The inflammatory role of platelets via their TLRs and Siglec receptors","volume":"6","author":"Cognasse","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanmic.2025.101255_bib14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.humimm.2014.09.013","article-title":"Human platelets express Toll-like receptor 3 and respond to poly I:C","volume":"75","author":"Anabel","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.lanmic.2025.101255_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00365-22","article-title":"Antiplatelet therapy in Staphylococcus aureus bacteremia: no time like the past?","volume":"66","author":"Mourad","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2025.101255_bib16","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.117.031164","article-title":"International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies","volume":"136","author":"Angiolillo","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.lanmic.2025.101255_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/apt.15059","article-title":"Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel","volume":"49","author":"Guo","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lanmic.2025.101255_bib18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ijcard.2013.06.135","article-title":"Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial","volume":"168","author":"DiNicolantonio","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lanmic.2025.101255_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jamacardio.2019.1189","article-title":"Antibacterial activity of ticagrelor in conventional antiplatelet dosages against antibiotic-resistant Gram-positive bacteria","volume":"4","author":"Lancellotti","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.lanmic.2025.101255_bib20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/infdis\/jiab146","article-title":"Ticagrelor increases platelet-mediated Staphylococcus aureus killing, resulting in clearance of bacteremia","volume":"224","author":"Ulloa","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101255_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd6737","article-title":"Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia","volume":"13","author":"Sun","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2025.101255_bib22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/toxins13100726","article-title":"Increased risk of thrombocytopenia and death in patients with bacteremia caused by high alpha toxin-producing methicillin-resistant Staphylococcus aureus","volume":"13","author":"Alhurayri","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.lanmic.2025.101255_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12879-023-08046-w","article-title":"Prognostic significance of early platelet dynamics in Staphylococcus aureus bacteremia","volume":"23","author":"Douglas-Louis","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101255_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105890","article-title":"Effect of antiplatelet agents on platelet antistaphylococcal capacity: an in vitro study","volume":"55","author":"Hannachi","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.lanmic.2025.101255_bib25","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/s41564-023-01486-9","article-title":"Systematic analysis of drug combinations against Gram-positive bacteria","volume":"8","author":"Cacace","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.lanmic.2025.101255_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010240","article-title":"Antiplatelet therapy for Staphylococcus aureus bacteremia: will it stick?","volume":"18","author":"Tatara","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanmic.2025.101255_bib27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fphar.2020.00863","article-title":"Antiplatelet agents have a distinct efficacy on platelet aggregation induced by infectious bacteria","volume":"11","author":"Hannachi","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.lanmic.2025.101255_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.716302","article-title":"Aspirin or ticagrelor in Staphylococcus aureus infective endocarditis: where do we stand?","volume":"9","author":"Leeten","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.lanmic.2025.101255_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2020.06.016","article-title":"Effect of ticagrelor on reducing the risk of Gram-positive infections in patients with acute coronary syndrome","volume":"130","author":"Lupu","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lanmic.2025.101255_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ehjcvp\/pvaa099","article-title":"Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections","volume":"8","author":"Butt","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.lanmic.2025.101255_bib31","article-title":"Propensity\u2013matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia","volume":"61","author":"Gentry","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.lanmic.2025.101255_bib32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2024.07.001","article-title":"Aspirin and ticagrelor versus aspirin and clopidogrel or prasugrel and the effect on staphylococcal-associated infections: a real-world study","volume":"46","author":"Essa","year":"2024","journal-title":"Clin Ther"},{"key":"10.1016\/j.lanmic.2025.101255_bib33","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ejim.2019.10.011","article-title":"Protective activity of ticagrelor against bacterial infection in acute myocardial infarction patients","volume":"70","author":"Rigatelli","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.lanmic.2025.101255_bib34","article-title":"Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel","volume":"61","author":"Gentry","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.lanmic.2025.101255_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02117-21","article-title":"Impact of clopidogrel on clinical outcomes in patients with Staphylococcus aureus bacteremia: a national retrospective cohort study","volume":"66","author":"Caffrey","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2025.101255_bib36","article-title":"Effects of adding P2Y12 inhibitor to anti-staphylococcal therapy on bacterial clearance in patients with Staphylococcus aureus bacteremia","volume":"16","author":"Mori","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.lanmic.2025.101255_bib37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.lanmic.2025.101255_bib38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2025.101255_bib39","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(10)61273-1","article-title":"Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the Triton-TIMI 38 trial: a pharmacogenetic analysis","volume":"376","author":"Mega","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101255_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(08)61845-0","article-title":"Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study","volume":"373","author":"Collet","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101255_bib41","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciac476","article-title":"The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foe","volume":"75","author":"Tong","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101255_bib42","author":"Rodr\u00edguez Ba\u00f1o"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:56:43Z","timestamp":1790283403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524725001831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666524725001831"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101255","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y12 inhibitors in Staphylococcus aureus bacteraemia: current evidence and clinical implications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101255"}}